ALAAF-STUDIE

Amphia studie LAat AFnavelen op de operatiekamer (OK)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON20503

Enrollment

100

Registered

2019-03-22

Start date

2019-05-01

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caesarean section

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Maternal criteria: Primary caesarean section, infants born between 37 and 42 weeks of gestational age (GA) Prenatal criteria: Prenatal screening without congenital abnormalities or syndromes

Exclusion criteria

Exclusion criteria: Secundary caesarean section for maternal or neonatal indication, gemelli pregnancy, maternal coagulation disorder, maternal irregular antibodies, maternal fever (> 38 degrees Celsius) prior to the caeserean section, prelabor rupture of the membranes (PROM) (> 24 hours), placenta praevia

Design outcomes

Primary

Measure	Time frame
Neonatal: Hemoglobin concentration (Ht), Hematocrit concentration (Ht)	—

Secondary

Measure	Time frame
Neonatal: APGAR score, rectal temperature, total serum bilirubin concentration at day 4, total ferritin concentration at age of 4 months Maternal: Total amount of blood loss, need for blood transfusion, maternal infection post-partum	—

Contacts

Public ContactEldin Krijgh

Amphia Hospital Breda

e.krijgh@erasmusmc.nl010-7040704

Outcome results